A retrospective study of risk factors for carbapenem-resistant klebsiella pneumoniae acquisition among ICU patients

Journal of Infection in Developing Countries

Volumn 10, Issue 3, 2016, Pages 208-213

  Hu, Yangmin ^a   Ping, Yanting ^a   Li, Leiqing ^a   Xu, Huimin ^a   Yan, Xiaofeng ^a   Dai, Haibin ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Antibiotics; Carbapenem; Klebsiella pneumoniae; Multidrug resistance; Risk factors

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM; BETA LACTAMASE; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; IMIPENEM; MEROPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE;

ADULT; ARTICLE; BIVARIATE ANALYSIS; BLOODSTREAM INFECTION; BRONCHOALVEOLAR LAVAGE FLUID; CENTRAL VENOUS CATHETER; CEREBROSPINAL FLUID ANALYSIS; DISK DIFFUSION; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE INFECTION; LEUKOCYTE COUNT; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; TERTIARY CARE CENTER; UNIVARIATE ANALYSIS; AGED; ANTIBIOTIC RESISTANCE; CASE CONTROL STUDY; CROSS INFECTION; DRUG EFFECTS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; TEACHING HOSPITAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CASE-CONTROL STUDIES; CROSS INFECTION; FEMALE; HOSPITALS, TEACHING; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; RISK FACTORS; TERTIARY CARE CENTERS;

EID: 84962374486     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.6697     Document Type: Article

References (28)

1. Giakkoupi P, Xanthaki A, Kanelopoulou M, Vlahaki A, Miriagou V, Kontou S, Papafraggas E, Malamou-Lada H, Tzouvelekis LS, Legakis NJ, Vatopoulos AC (2003) VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals. J Clin Microbiol 41: 3893-3896.
2. Woodford N, Tierno PM, Jr., Young K, Tysall L, Palepou MF, Ward E, Painter RE, Suber DF, Shungu D, Silver LL, Inglima K, Kornblum J, Livermore DM (2004) Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother 48: 4793-4799.
3. Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M, Quale J (2005) Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 165: 1430-1435.
4. Ikonomidis A, Tokatlidou D, Kristo I, Sofianou D, Tsakris A, Mantzana P, Pournaras S, Maniatis AN (2005) Outbreaks in distinct regions due to a single Klebsiella pneumoniae clone carrying a bla VIM-1 metallo-{beta}-lactamase gene. J Clin Microbiol 43: 5344-5347.
5. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y (2007) Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 51: 3026-3029.
6. Kochar S, Sheard T, Sharma R, Hui A, Tolentino E, Allen G, Landman D, Bratu S, Augenbraun M, Quale J (2009) Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 30: 447-452.
7. Van Duin D, Kaye KS, Neuner EA, Bonomo RA (2013) Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis 75: 115-120.
8. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y (2008) Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52: 1028-1033.
9. Debby BD, Ganor O, Yasmin M, David L, Nathan K, Ilana T, Dalit S, Smollan G, Galia R (2012) Epidemiology of carbapenem resistant Klebsiella pneumoniae colonization in an intensive care unit. Eur J Clin Microbiol Infect Dis 31: 1811-1817.
10. Kofteridis DP, Valachis A, Dimopoulou D, Maraki S, Christidou A, Mantadakis E, Samonis G (2014) Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization: A case-case-control study. J Infect Ch 20: 293-297.
11. Brusselaers N, Vogelaers D, Blot S (2011) The rising problem of antimicrobial resistance in the intensive care unit. Ann Intensive Care 1: 47.
12. Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R (2009) Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 30: 666-671.
13. Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Sklavou C, Vamvakopoulou S, Anastassiou ED, Filos KS (2013) KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis 77: 169-173.
14. Mantzarlis K, Makris D, Manoulakas E, Karvouniaris M, Zakynthinos E (2013) Risk factors for the first episode of Klebsiella pneumoniae resistant to carbapenems infection in critically ill patients: a prospective study. Biomed Res Int 2013: 850547.
15. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) Control Disease Center definitions for nosocomial infections, 1988. Am J Infect Control 16: 128-140.
16. Clinical and Laboratory Standards Institute (2010) Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement. Document M100-S20. Wayne, PA: CLSI.
17. Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G, Michalopoulos A (2007) Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother 60: 1124-1130.
18. Kritsotakis EI, Tsioutis C, Roumbelaki M, Christidou A, Gikas A (2011) Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. J Antimicrob Ch 66: 1383-1391.
19. Mouloudi E, Protonotariou E, Zagorianou A, Iosifidis E, Karapanagiotou A, Giasnetsova T, Tsioka A, Roilides E, Sofianou D, Gritsi-Gerogianni N (2010) Bloodstream infections caused by metallo-beta-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol 31: 1250-1256.
20. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP (2008) Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 29: 1099-1106.
21. Kwak YG, Choi SH, Choo EJ, Chung JW, Jeong JY, Kim NJ, Woo JH, Ryu J, Kim YS (2005) Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microb Drug Resist 11: 165-169.
22. Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO (2009) Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 30: 1180-1185.
23. Rafailidis PI, Bliziotis IA, Falagas ME (2010) Case-control studies reporting on risk factors for emergence of antimicrobial resistance: bias associated with the selection of the control group. Microb Drug Resist 16: 303-308.
24. Hyle EP, Bilker WB, Gasink LB, Lautenbach E (2007) Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection. Infect Control Hosp Epidemiol 28: 647-654.
25. Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, Gal-Mor O, Maor Y, Rahav G (2012) Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 18: 54-60.
26. Daikos GL, Petrikkos P, Psichogiou M, Kosmidis C, Vryonis E, Skoutelis A, Georgousi K, Tzouvelekis LS, Tassios PT, Bamia C, Petrikkos G (2009) Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 53: 1868-1873.
27. Borer A, Saidel-Odes L, Riesenberg K, Eskira S, Peled N, Nativ R, Schlaeffer F, Sherf M (2009) Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 30: 972-976.
28. Safdar N, Maki DG (2002) The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 136: 834-844.